EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Psychometric evaluation of the Adherence to Refills and Medications Scale (ARMS) in Australians living with gout

Marcel Schulz, Richard O Day, Matthew J Coleshill, Nancy E Briggs, Eindra Aung

Clinical Rheumatology · 2024

DOI: 10.1007/s10067-024-07050-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Rheumatology, 2024. Verfasst von Marcel Schulz und 4 weiteren Autor:innen. Beteiligte Einrichtung: St Vincent's Clinical Campus, School of Clinical Medicine, UNSW, Sydney, NSW, Australia. Hauptthemen laut MEDLINE: Gout, Psychometrics, Gout Suppressants, Drug Monitoring. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, Department of Education, Australian Government, St Vincent’s Centre for Applied Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aimed to examine psychometric properties of the Adherence to Refills and Medications Scale (ARMS) in people with gout. We conducted exploratory factor analysis (EFA) and tested internal consistency (ordinal and Cronbach’s alpha coefficients) and agreement (intraclass correlation coefficient (2,1)) in ARMS scores across three timepoints (baseline, 6, and 12 months) in 487 people with gout. The Kruskal–Wallis test, Spearman’s rank, Kendall’s tau-b correlations, and logistic regression were used to examine the criterion-related validity of the ARMS and factors associated with the ARMS. EFA suggested a one-factor structure, explaining 43.2% of total variance. High internal consistency (ordinal alpha = 0.902 at baseline) and moderate agreement in ARMS scores over time (ICCs > 0.5; p < 0.001) were observed. Lower ARMS scores (indicating better adherence) predicted achieving target serum urate (OR, 0.89; 95% CI, 0.83–0.95; p < 0.001), but not urate-lowering therapy (ULT) adherence (Proportion of Days Covered (PDC) ≥ 80%) (OR, 0.93; 95% CI, 0.81–1.05; p = 0.261). Negative correlations between ARMS and PDC were not statistically significant (Kendall’s tau-b, r = − 0.126, p = 0.078; Spearman’s rho = − 0.173, p < 0.073). Differences in median ARMS scores (IQR) of 16 (14–20), 13 (12–15), and 17.5 (15–21) in three groups of participants who reported (1) not taking ULT, (2) taking ULT and adherent, and (3) taking ULT but not adherent, respectively, were statistically significant ( p < 0.001). Age was the only patient factor independently associated with optimal adherence (ARMS score = 12) (OR, 1.91; 95% CI, 1.50–2.43; p < 0.001). The ARMS is a reliable and valid measure of medication adherence behaviours in people with gout, justifying its use in gout medication adherence research. Key Points • Valid, practical, and efficient methods of measuring adherence to medications are needed in people with gout. • Commonly used medication adherence questionnaires have limited validity or have not been validated in people with gout. • The Adherence to Refills and Medications Scale (ARMS) has been proven valid and practical in many chronic illnesses but has not been validated in people with gout. • We showed the ARMS is valid and reliable for use in people with gout.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GoutPsychometricsGout SuppressantsDrug MonitoringHumansMaleFemaleMiddle AgedAgedAustraliaAdultSurveys and QuestionnairesUric AcidFactor Analysis, StatisticalReproducibility of ResultsLogistic ModelsAustralasian People

Stichwörter der Autor:innen

Adherence to Refills and Medications Scale (ARMS)GoutMedication adherenceReliabilityUrate-lowering therapy (ULT)Validity

Substanzen

Gout SuppressantsUric Acid

Autor:innen und Institutionen

  • St Vincent's Clinical Campus, School of Clinical Medicine, UNSW, Sydney, NSW, Australia.
  • St Vincent's Clinical Campus, School of Clinical Medicine, UNSW, Sydney, NSW, Australia. r.day@unsw.edu.au.
  • Department of Clinical Pharmacology & Toxicology, St Vincent's Hospital Sydney, Victoria Street, Darlinghurst, NSW, 2010, Australia. r.day@unsw.edu.au.
  • Department of Clinical Pharmacology & Toxicology, St Vincent's Hospital Sydney, Victoria Street, Darlinghurst, NSW, 2010, Australia.
  • Black Dog Institute, Sydney, NSW, Australia.
  • Stats Central, Mark Wainwright Analytical Centre, UNSW, Sydney, Australia.

Förderung

  • National Health and Medical Research Council
  • Department of Education, Australian Government
  • St Vincent’s Centre for Applied Medical Research
  • University of New South Wales

Zitieren

APA

Schulz, M., Day, R. O., Coleshill, M. J., Briggs, N. E., & Aung, E. (2024). Psychometric evaluation of the Adherence to Refills and Medications Scale (ARMS) in Australians living with gout. Clinical Rheumatology. https://doi.org/10.1007/s10067-024-07050-y

Vancouver

Schulz M, Day RO, Coleshill MJ, Briggs NE, Aung E. Psychometric evaluation of the Adherence to Refills and Medications Scale (ARMS) in Australians living with gout. Clinical Rheumatology. 2024. doi:10.1007/s10067-024-07050-y

BibTeX
@article{Schulz2024,
  author = {Schulz, Marcel and Day, Richard O and Coleshill, Matthew J and Briggs, Nancy E and Aung, Eindra},
  title = {Psychometric evaluation of the Adherence to Refills and Medications Scale (ARMS) in Australians living with gout},
  journal = {Clinical Rheumatology},
  year = {2024},
  doi = {10.1007/s10067-024-07050-y}
}
Kostenlos starten →